Sasaki Yohei, Shimizu Yoshio, Suzuki Yusuke, Horikoshi Satoshi, Tomino Yasuhiko
Division of Nephrology, Department of Internal Medicine, Juntendo University Faculty of Medicine, 2-1-1, Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
BMC Nephrol. 2015 Mar 14;16:27. doi: 10.1186/s12882-015-0022-8.
The TNF-like weak inducer of apoptosis (TWEAK) contributes to kidney inflammation producing secretion by renal cells. The present study examined whether the level of TWEAK is associated with histologic findings in patients with IgA nephropathy (IgAN).
The levels of urinary TWEAK (uTWEAK) from 116 IgAN patients, 50 non-IgA kidney disease patients, and 50 healthy individuals were measured by ELISA. Histological findings of renal biopsy specimens of patients with IgAN were evaluated according to the Oxford classification and histological classification for IgAN in Japan. We investigated the expression of TWEAK/Fn14 in renal tissues of those patients and assessed the effect of TWEAK in glomerular mesangial cells and podocytes.
The levels of uTWEAK in the patients with IgAN and other renal diseases were significantly higher than in the healthy controls (P < 0.001). In the IgAN patients, the levels of uTWEAK correlated significantly with urinary protein excretion and extracapillary proliferation (r = 0.54, P < 0.001 and r = 0.32, P < 0.001, respectively). In a comparison of the levels of uTWEAK at diagnosis with that of follow-up, the levels of uTWEAK in patients with clinical and partial remission decreased significantly. We showed not only increased expression of both TWEAK and Fn14 in IgAN patients with glomerular crescents but also TWEAK-induced cell motility in podocytes.
The relationship between the levels of uTWEAK and clinicopathological findings observed in this study suggests that TWEAK/Fn14 system affects crescent formation and proteinuria in patients with IgAN.
肿瘤坏死因子样凋亡微弱诱导剂(TWEAK)通过肾细胞分泌促成肾脏炎症。本研究检测了TWEAK水平是否与IgA肾病(IgAN)患者的组织学表现相关。
采用酶联免疫吸附测定法(ELISA)检测116例IgAN患者、50例非IgA肾病患者及50例健康个体的尿TWEAK(uTWEAK)水平。根据牛津分类法和日本IgAN组织学分类法评估IgAN患者肾活检标本的组织学表现。我们研究了这些患者肾组织中TWEAK/Fn14的表达,并评估了TWEAK对肾小球系膜细胞和足细胞的作用。
IgAN患者和其他肾脏疾病患者的uTWEAK水平显著高于健康对照组(P<0.001)。在IgAN患者中,uTWEAK水平与尿蛋白排泄及毛细血管外增生显著相关(r分别为0.54,P<0.001和r为0.32,P<0.001)。比较诊断时与随访时的uTWEAK水平,临床缓解和部分缓解患者的uTWEAK水平显著降低。我们发现,在有肾小球新月体的IgAN患者中,TWEAK和Fn14的表达均增加,且TWEAK可诱导足细胞的细胞运动。
本研究中观察到的uTWEAK水平与临床病理表现之间的关系表明,TWEAK/Fn14系统影响IgAN患者的新月体形成和蛋白尿。